D. E. Shaw & Co., Inc. Sema4 Holdings Corp. Transaction History

D. E. Shaw & Co., Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.22 - $1.04 $56,208 - $265,712	-255,493 Reduced 28.21%	650,122 $169,000
Q3 2022 Nov 14, 2022	SELL	$0.25 - $2.4 $537,707 - $5.16 Million	-2,150,829 Reduced 70.37%	905,615 $795,000
Q2 2022 Aug 15, 2022	BUY	$1.22 - $3.05 $1.49 Million - $3.73 Million	1,221,431 Added 66.56%	3,056,444 $3.85 Million
Q1 2022 May 16, 2022	BUY	$2.64 - $4.67 $1.08 Million - $1.9 Million	407,922 Added 28.58%	1,835,013 $5.63 Million
Q4 2021 Feb 14, 2022	BUY	$4.4 - $8.8 $112,327 - $224,655	25,529 Added 1.82%	1,427,091 $6.37 Million
Q3 2021 Nov 15, 2021	BUY	$7.44 - $13.99 $10.4 Million - $19.6 Million	1,401,562 New	1,401,562 $10.6 Million

166K

Ticker SMFR
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 380,641,984
Market Cap $129M
Description
Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commerc...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.